Skip to main content Skip to navigation

Licensing deal with Genus will help combat deadly cattle disease

First published in WSU News

A gene editing technology developed at WSU is being licensed to Genus plc, a global animal genetics company, to develop cattle that are more resistant to bovine respiratory disease (BRD).

“From domestication and selective breeding to today’s use of advanced biotechnology, the goal of all animal husbandry remains the same,” said Bryan Slinker, dean of WSU’s College of Veterinary Medicine.  “The goal is to continue to optimize animal health and well-being and produce disease-free food animals.  This work is another important step in ensuring we meet our responsibilities to animals as well as the world’s food supply, now and in the future.”

» More …

Scientist develops gene therapy for muscle wasting

First published for WSU News by Seth Truscott

A discovery by Washington State University scientist Dan Rodgers and collaborator Paul Gregorevic could save millions of people suffering from muscle wasting disease.

The result of the team’s four-year project is a novel gene therapeutic approach. The work was published (http://stm.sciencemag.org/content/8/348/348ra98) July 20 in Science Translational Medicine, a journal of the American Association for the Advancement of Science.

“Chronic disease affects more than half of the world’s population,” said Rodgers, professor of animal sciences (https://ansci.wsu.edu/people/faculty/dan-rodgers/) and director of the Washington Center for Muscle Biology (http://wcmb.wsu.edu/). “Most of those diseases are accompanied by muscle wasting.

“It occurs with chronic infection, muscular dystrophy, malnutrition and old age,” he said. “About half the people who die from cancer are actually dying from muscle wasting and there’s not one single therapy out there that addresses it. » More …